Back to search

Article

OCRL is a novel prognostic biomarker and its association with immunoregulation in breast cancer

2022-09-16

Abstract excerpt

<h4>Background: </h4> OCRL (Oculocerebrorenal syndrome of Lowe Protein) was originally well-known as the Lowe’s protein. However, the expression, significance and regulation mechanisms of OCRL in any cancers were not clear. <h4>Methods: </h4>: The bioinformation of breast cancer (BC) patients was required from TCGA (The Cancer Genome Atlas), and the expression was validated via IHC (immuno-histochemical analysis)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bfe43425-209f-5cf7-b27c-1d9382405be6
DOI
10.21203/rs.3.rs-2032108/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
OCRL is a novel prognostic biomarker and its association with immunoregulation in breast cancerDOI 10.21203/rs.3.rs-2032108/v1
Select a neighboring publication to make it the new centre.